In-vitro antileishmanial potential of peptide drug hirudin.

Bibliographic Details
Title: In-vitro antileishmanial potential of peptide drug hirudin.
Authors: Khan, Hanif1, Nadhman, Akhtar2 akhtar.nadhman@iiu.edu.pk, Azam, Syed Sikander3, Anees, Mariam1 mariam@qau.edu.pk, Khan, Imran2, Ullah, Ikram2, Sohail, Muhammad Farhan4, Shahnaz, Gul4, Yasinzai, Masoom2
Source: Chemical Biology & Drug Design. Jan2017, Vol. 89 Issue 1, p67-73. 7p.
Subject Terms: *HIRUDIN, *LEISHMANIASIS treatment, *PROTEINASES, *MACROPHAGES, *CELL-mediated cytotoxicity, *THERAPEUTICS
Abstract: Hirudin is clinically an important drug used for the treatment of cardiac diseases, but has never been elucidated for antileishmanial potential. This study was designed to determine the therapeutic utility of hirudin against leishmaniasis. Binding affinities of 28 potent proteinase inhibitors were screened computationally against leishmanolysin ( GP63), out of which hirudin exhibited higher binding affinity with GP63 and good expected IC50 values. Experimentally, hirudin showed most promising activity against promastigote and axenic amastigote forms of leishmanial parasites with IC50 values of 0.60 ± 0.36 μg/mL and 0.43 ± 0.23 μg/mL, respectively, in a dose- and time-dependent assay. The cytotoxicity assay revealed no adverse effects on human macrophages with LD50 value of 860.11 ± 53.44 μg/mL. Hirudin caused leishmanial cell death mainly by apoptosis and membrane permeability. In spite of the basic knowledge obtained, hirudin mechanism is considerably less prone to the induction of resistance than classical drugs. Collectively, this study fosters further studies for the hirudin as new antileishmania lead with a new mode of action. [ABSTRACT FROM AUTHOR]
Copyright of Chemical Biology & Drug Design is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
More Details
ISSN:17470277
DOI:10.1111/cbdd.12831
Published in:Chemical Biology & Drug Design
Language:English